(Q46178239)
Statements
1 reference
Phase I and pharmacokinetic study of gimatecan given orally once a week for 3 of 4 weeks in patients with advanced solid tumors (English)
1 reference
Andrew X Zhu
1 reference
Neal Ready
1 reference
Jeffrey W Clark
1 reference
Howard Safran
1 reference
Antonino Amato
1 reference
Nadia Salem
1 reference
Silvia Pace
1 reference
Xiaoying He
1 reference
Nela Zvereva
1 reference
Thomas J Lynch
1 reference
David P Ryan
1 reference
Jeffrey G Supko
1 reference
1 January 2009
1 reference
15
1 reference
1
1 reference
374-381
1 reference